title: Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.
authors.forename: P
authors.initials: P
authors.lastname: Stryckmans
authors.forename: T
authors.initials: T
authors.lastname: De Witte
authors.forename: J P
authors.initials: JP
authors.lastname: Marie
authors.forename: G
authors.initials: G
authors.lastname: Fillet
authors.forename: M
authors.initials: M
authors.lastname: Peetermans
authors.forename: J
authors.initials: J
authors.lastname: Bury
authors.forename: P
authors.initials: P
authors.lastname: Muus
authors.forename: J M
authors.initials: JM
authors.lastname: Andrien
authors.forename: M
authors.initials: M
authors.lastname: Hayat
authors.forename: B
authors.initials: B
authors.lastname: Jaksic
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction; D016019:Survival Analysis; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D003561:Cytarabine